Terms: = Endocrine gland cancer AND MSH6, GTBP, P52701, 2956, ENSG00000116062, HSAP, HNPCC5 AND Staging
3 results:
1. Ovarian Mesonephric-Like Adenocarcinoma With Recurrent Liver Metastases: A Case Report with Analysis of Therapeutic Molecular Targets.
Sugitani A; Ogawa A; Yoshida H; Kobayashi-Kato M; Kikkawa N; Tanase Y; Uno M; Ishikawa M; Kato T
Int J Surg Pathol; 2024 May; 32(3):578-585. PubMed ID: 37345348
[TBL] [Abstract] [Full Text] [Related]
2. Setting the bar: compliance with ovarian cancer quality indicators at a National cancer Institute-designated Comprehensive cancer Center.
Liang MI; ElNaggar AC; Nekkanti S; O'Malley DM; Hade EM; Copeland LJ; Fowler JM; Salani R; Backes FJ; Cohn DE
Gynecol Oncol; 2015 Sep; 138(3):689-93. PubMed ID: 26216728
[TBL] [Abstract] [Full Text] [Related]
3. Survival in women with MMR mutations and ovarian cancer: a multicentre study in Lynch syndrome kindreds.
Grindedal EM; Renkonen-Sinisalo L; Vasen H; Evans G; Sala P; Blanco I; Gronwald J; Apold J; Eccles DM; Sánchez AA; Sampson J; Järvinen HJ; Bertario L; Crawford GC; Stormorken AT; Maehle L; Moller P
J Med Genet; 2010 Feb; 47(2):99-102. PubMed ID: 19635727
[TBL] [Abstract] [Full Text] [Related]